BioSpace News Archive

I-Mab Biopharma and ABL Bio Corporation jointly announced that two companies had entered into a strategic partnering agreement for ABL Bio to in-license the global rights excluding Greater China to I-Mab’s bispecific antibodies

Engaging educational video aims to reach 1 in 7 Americans diagnosed with migraine

New offerings from Siemens Healthineers leverage expertise, software, and open connectivity labs need to optimize operations.

The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) (“ACADIA”) on behalf of purchasers of ACADIA securities between April 29, 2016 and July 9, 2018, inclusive (the “Class Period”).

Leading dermatology EHR company showcases new functionality at Summer AAD 2018

Personalis, Inc., a leading provider of advanced genomic sequencing and analytics for immuno-oncology (IO), today announced that it has received approval from the New York State Department of Health for use of ACE ImmunoID, its next-generation sequencing platform for the development of personalized cancer vaccines and IO biomarker discovery, in cancer immunotherapy clinical trials.

The podcast features in-depth conversations with oncology experts

Publicly available report offers important tools and guidance for all healthcare systems [26-July-2018] PLYMOUTH MEETING, Pa., July 26, 2018 /PRNewswire/ -- The Partnership for Health IT Patient Safety , a multi-stakeholder collaborative convened and operated by ECRI Institute, released a new report today that identifies ways that technology can reduce a

On February 6, 2018, Sinovac Biotech Ltd. held its 2017 Annual Meeting of Shareholders in Beijing, China.

Monash plant scientists have discovered a new molecular mechanism of gene regulation, which could have major implications for the development of treatment strategies for Friedreich’s ataxia -- a debilitating genetic disorder that causes damage to the nervous system.